Login
$CV
$6.75 -$0.14 (2.03%) Close

$CV SEC Filings

Filed On Filing
28 Sep 2026 8-K: Other Events

AI-assisted reading tool designed to aid physician review of small bowel capsule endoscopy studies performed due to suspected bleeding using the CapsoCam Plus® system

23 Sep 2026 Form 4/A: Shen Ching Hang, 10% owner

Disposed of 3,991,606 shares (Other Transaction) · Acquired 3,991,606 shares (Other Transaction)

23 Sep 2026 Form 4/A: Shen Ching Hang, 10% owner

Bought 878,734 shares ($5M)

23 Sep 2026 Form 4: Harari Eliyahou Et Al, 10% owner

Bought 1,757,469 shares ($10M)

18 Sep 2026 Form 4: Shen Ching Hang, 10% owner

Bought 878,734 shares ($5M)

18 Sep 2026 8-K: Entry into a Material Definitive Agreement

Certain confidential information contained in this document, marked by [* * *], has been omitted pursuant to Item 601 (b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant ...

18 Sep 2026 424B5
21 Aug 2026 EFFECT
21 Aug 2026 424B5
18 Aug 2026 8-K: Other Events
13 Aug 2026 S-3
13 Aug 2026 10-Q
13 Aug 2026 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition
21 Jul 2026 Form 4: Harari Eliyahou Et Al, 10% owner

Bought 61,068 shares ($411K)

10 Jul 2026 Form 4: Harari Eliyahou Et Al, 10% owner

Bought 81,300 shares ($495K)

07 Jul 2026 Form 4: Harari Eliyahou Et Al, 10% owner

Bought 13,850 shares ($102K)

02 Jul 2026 Form 4: Shields David Stanley, Director

Granted 1,710 Restricted Stock Unit (RSU)

02 Jul 2026 Form 3: Shields David Stanley, Director

Holds 0 shares of Common Stock

02 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
01 Jul 2026 Form 4: Imperial Joanne Carol, Director

Received 2,022 shares by exercise or conversion ($15.3K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support